Among outpatients with hyperkalemia , open-label sodium zirconium cyclosilicate reduced serum potassium to normal levels within 48 hours ; compared with placebo , all 3 doses of zirconium cyclosilicate resulted in lower potassium levels and a higher proportion of patients with normal potassium levels for up to 28 days .